Results

Total Results: 404 records

Showing results for "vascular".

61. Noninvasive Testing for Coronary Artery Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
    January 15, 2015 - responses through an imbalance of chemical mediators of vasorelaxation and vasoconstriction, termed vascular … The pathophysiologic changes in coronary artery anatomic structure (including deposition of plaque), vascular … include those related to local anesthesia and use of contrast material, as well as infection, local vascular … probable) • Possible ECG changes (e.g., T-wave, NSTEMI) or nondiagnostic ECG • Presence of other vascular … nephrogenic systemic fibrosis, contrast-related harms, adverse reactions to drugs for stress tests), vascular

62. Microsoft Word - finbody.doc (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
    January 01, 2007 - We combined search terms for renal artery stenosis, renal hypertension, and renal vascular disease, … Tier III Other comparative studies that compared angioplasty or vascular surgery to medical therapy … Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. … Pillay WR, Kan YM, Crinnion JN, Wolfe JH, Joint Vascular Research Group. … Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography.

63. Identifying Signals for Updating Systematic Reviews: A Comparison of Two Methods | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/signals/research

64. Tratamiento del hemangioma infantil en niños | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/infantile-hemangioma/espanol

65. Clopidogrel after Drug-Eluting Stent Implantation: Is current practice sufficient (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
    March 01, 2009 - Eisenstein reported receiving research grants from Medtronic Vascular. Dr. … and Quality, Proctor and Gamble, Pfizer, Medtronic, Alexion Pharmaceuticals, Medicure, Medtronic Vascular … Califf reported research grants or contracts from Abbott Vascular Devices, Advanced Cardiovascular … valvular heart disease, third heart sound, history of cerebrovascular disease, history of peripheral vascular

66. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
    September 02, 2016 - [mp=ti, ot, ab, nm, hw, kw, kf, px, rx, ui, an, tx, sh, ct, bt, id, cc] 62. exp peripheral vascular … (peripheral and vascular and disease$).mp. … statin) O • Must mention CVD (or BP or lipids) in abstract • All-cause mortality • Cerebro/cardio-vascular … stroke/CVA, TIA, unstable angina, amputation 2° PVD, others o coronary/cardiac disease o peripheral vascular … cardiovascular invasive interventions (revascularization) § CABG (bypass), PCI (coronary angioplasty), vascular

67. Omega−3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
    August 01, 2016 - may impact the purported CV benefits of n-3 FA, including lipid metabolism, blood pressure (BP) and vascular … reported in the previous review and expands the scope to include additional CVD outcomes (peripheral vascular … of quantiles) Outcomes • All-cause death • Cardiovascular (CV), cerebrovascular, and peripheral vascular … events: o Fatal vascular events (e.g., due to MI, stroke) o Total incident vascular events (e.g … � For peripheral vascular disease event, incident hypertension, MACE, and revascularization outcomes

68. Management of Uterine Fibroids - Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
    December 01, 2017 - characteristics (e.g., age; race/ ethnicity; symptoms; menopausal status; imaging characteristics; vascular … characteristics (e.g., age; race/ethnicity; symptoms; menopausal status; imaging characteristics; vascular … Journal of vascular and interventional radiology : JVIR. 2014;25(6):823-832. 14. … Journal of vascular and interventional radiology : JVIR. 2011;22(9):1229-1235. 16. … Journal of vascular and interventional radiology : JVIR. 2005;16(11):1431-1437. 24.

69. Omega 3 Fatty Acids and Cardiovascular Disease - Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/research-protocol

70. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/research

71. Omega-3 Fatty Acids and Cardiovascular Disease | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/consumer

72. Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/atrial-fibrillation-ablation/research

73. Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/heart-disease-ace-inhibitor-arb-future/research

74. Pulmonary Arterial Hypertension: Screening, Management, and Treatment | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/hypertension-pulmonary-arterial/research-protocol

75. Comparative Effectiveness of Adjunctive Devices to Remove Thrombi or Protect Against Distal Embolization in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention of Native Vessels | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/acs-pci-adjunctive-devices/research-protocol

76. Adjunctive Devices for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/acs-pci-adjunctive-devices/research

77. Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/clinician

78. Utilization and Clinical Data on In-Hospital Off-Label Uses of Recombinant Factor VIIa | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/recombinant-factor-viia/clinician

79. Treatment Strategies for Patients With Peripheral Artery Disease (PAD) | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-treatment/research-protocol

80. Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research